NCT00408005 2025-04-20
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
National Cancer Institute (NCI)
Phase 3 Completed
Clinical Trials
7 trialsNCT03328104 2023-07-21
ENCERT
Emory University
Phase 1 Completed
NCT00684619 2022-08-18
506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL)
Goethe University
Phase 2 Completed
NCT00406757 2017-11-13
Clinical Evaluation of Nelarabine (506U78)in Japanese Patients With Leukemia or Lymphoma
GlaxoSmithKline
Phase 1 Completed
NCT00866671 2015-01-14
Observational Study of Nelarabine in Children and Young Adults
GlaxoSmithKline
Completed
NCT00003545 2013-02-05
506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00005080 2013-01-16
506U78 in Treating Patients With Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed